| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2009 | CN100450487C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 01/14/2009 | CN100450486C Application of dipyridamole in preparation of anti-malignant tumor medicine |
| 01/14/2009 | CN100450485C 5-HT 1a receptor subtype agonists |
| 01/14/2009 | CN100450484C Imiquimod turbid liquor and gelling agent thereof |
| 01/14/2009 | CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers |
| 01/14/2009 | CN100450482C Transdermaltherapeutic system containing a pramipexol active agent |
| 01/14/2009 | CN100450481C Compound medicine contg. famotidine cyclodextrin clathrate, and its prepn. method |
| 01/14/2009 | CN100450480C Aquogel type thiamazole plaster preparation |
| 01/14/2009 | CN100450479C Medication in use for bacteriostasis and antiinflammation |
| 01/14/2009 | CN100450478C Pharmaceutical composition |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450476C Electrolyte complementary medical combination for injection |
| 01/14/2009 | CN100450475C Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 01/14/2009 | CN100450474C Physiological cooling compositions |
| 01/14/2009 | CN100450473C Aseptic medicinal composition |
| 01/14/2009 | CN100450471C Soft capsule of atovastatine salts and prepn. method therefor |
| 01/13/2009 | US7476767 Alpha-hydroxy sulfonate aldehydes, germicidal compositions containing the alpha-hydroxy sulfonate aldehydes, or mixtures of alpha-hydroxy sulfonate aldehydes and phthalaldehydes, and methods of using the compounds or compositions for disinfection or sterilization |
| 01/13/2009 | US7476763 e.g. 5-oxo-5-phenyl-valeric acid 4-dimethylamino-4-phenyl-cyclohexyl)-amide; opioid receptor modulator; noradrenaline and serotonin reuptake inhibitor; antidepressant, anxiolytic, analgesic agent; neurodegenerative diseases; linking a cyclohexane-1,4-diamine with a carboxylic acid |
| 01/13/2009 | US7476758 excellent inhibitory activity against alpha 4 integrin-mediated cell adhesion; allergic bronchitis, inflammatory bowel disease, rheumatoid arthritis, experimental autoimmune encephalomyelitis |
| 01/13/2009 | US7476756 Alkyl-, alkenyl- and alkynylcarbamate derivatives, their preparation and their application in therapeutics |
| 01/13/2009 | US7476755 e.g. 5-(3-{(1S,2S)-2-[4-(1-Hydroxy-hexyl)-phenyl]-3-oxo-cyclopentyl}-propyl)-thiophene-2-carboxylic acid; prostaglandin receptor ligand; antiinflammatory agent; glaucoma or ocular hypertension |
| 01/13/2009 | US7476754 Biphenyl derived thiamides as calpain inhibitors |
| 01/13/2009 | US7476748 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
| 01/13/2009 | US7476747 Substituted gamma lactams as therapeutic agents |
| 01/13/2009 | US7476746 PPAR active compounds |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476743 Treating cellular proliferation disease with 1,2,5-triazol-5-one and as an anticancer agent and inhibitor of kinesins for treatment of hyperplasia or restenosis |
| 01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 01/13/2009 | US7476741 Treating proliferative disorders such as cancer, autoimmune or inflammatory diseases such as psoriasis; e.g. 4-(3-Bromo-4,5-dimethoxyphenyl)-3-cyano-7-dimethylamino-4H-chromene; use with known anticancer drugs or radiotherapy |
| 01/13/2009 | US7476740 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 01/13/2009 | US7476732 Nucleic acid encoding α chain of human IL-11 receptor |
| 01/13/2009 | US7476729 Dbait and uses thereof |
| 01/13/2009 | US7476725 two polymer molecules attached at a single site on a biomolecule; water soluble and have beneficial pharmacological properties, such as reduced immunogenicity and increased circulation time |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476693 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 01/13/2009 | US7476692 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion |
| 01/13/2009 | US7476691 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
| 01/13/2009 | US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 01/13/2009 | US7476689 Therapeutic compositions for intranasal administration which include KETOROLAC |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476685 Pyridine carboxamide derivatives and their use as pesticides |
| 01/13/2009 | US7476684 Compounds for the treatment of neurological, psychiatric or pain disorders |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476681 anticarcinogenic agent; prostate cancer, benign prostatic hyperplasia, prostatic intraepithelial neoplasia, hirsutism, acne, androgenic alopecia, or polycystic ovary syndrome, prostate, lung, pancreatic, colon, renal cancer, myeloid leukemia |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476679 e.g. N-(4a-(3-Methoxyphenyl)-8a-methyl-2-(3-phenylpropyl)octahydroisoquinolin-6-yl]-3-piperidin-1-yl-propionamide; opioid receptor antagonist; analgesic, antidepressant; nervous system disorder; drug abuse, obesity |
| 01/13/2009 | US7476678 Rapamycin derivatives and the uses thereof in the treatment of neurological disorders |
| 01/13/2009 | US7476677 Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of Tie2 |
| 01/13/2009 | US7476676 Administering to the mammal an effective amount of a GSK-3 beta (glycogen synthase kinase-3 beta) to promote bone formation and treat bone metabolic diseases such as osteoporosis |
| 01/13/2009 | US7476675 Quinolinone derivatives and uses thereof |
| 01/13/2009 | US7476674 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/13/2009 | US7476672 Acetylenic compounds useful in treating inflammatory disorders |
| 01/13/2009 | US7476671 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 01/13/2009 | US7476670 anticancer/antiproliferative activity; antifungal agents; protein kinases inhibitors in perticular Focal Adhesion Kinase inhibitors and fungal CIV1 protein kinase inhibitors; N-[6-(5,6-dichloro-2,3-dihydro-1H-indol-1-yl)-9H-purin-2-yl]-1,4-cyclohexanediamine dihydrochloride |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476668 Thiadiazine derivatives and use thereof as positive AMPA receptor modulators |
| 01/13/2009 | US7476667 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 01/13/2009 | US7476666 HIV integrase inhibitors |
| 01/13/2009 | US7476665 Benzodiazepine CGRP receptor antagonists |
| 01/13/2009 | US7476664 Bis-2-difluoro-pyrrolo[2,1-C][1,4]benzodiazepine dimers |
| 01/13/2009 | US7476663 Substituted thiophene carboxamides |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | US7476660 Composition and method for organ preservation |
| 01/13/2009 | US7476659 Especially a chitosan in which the amine group is substituted with a photocurable carbonylazide, sulfonylazide, aromatic azide, or formyl styryl group and irradiating with light during surgery to form an insoluble hydrogel |
| 01/13/2009 | US7476658 Conjugate for treating prokaryotic infections |
| 01/13/2009 | US7476547 contacting a blood cell-containing sample with a composition comprising: soluble dextran; anti-glycophorin A antibody; anti-CD15 antibody; and anti-CD9 antibody; allowing sample to partition into an agglutinate and a supernatant phase; and recovering said cells from agglutinate or supernatant phase |
| 01/13/2009 | US7476539 DNA containing variant FRT sequences |
| 01/13/2009 | US7476404 Osteoporosis; vitamin D; Calcium Citrate Malate; Potassium Citrate; Magnesium; Boron and Vitamin K |
| 01/13/2009 | US7476402 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 01/13/2009 | US7476400 Liposomes containing an oil phase comprising topical anestheic, a C14-C20 alcohol, an alkyl ester of a fatty acid, propylene glycol, and a polyoxyalkylene stearate. |
| 01/13/2009 | US7476396 Composition for removing abnormal keratinous material |
| 01/13/2009 | US7476392 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 01/13/2009 | US7476383 Antiproliferative agent; induction apoptosis; antitumor agents |
| 01/13/2009 | US7476380 Using vitamin A and/or the derivatives and/or the esters for therapy and prophylaxis, side effect reduction |
| 01/13/2009 | US7476379 Animal oils/extracts (from Emu), bezoin, alkyl ester, allantoin, methylparaben, and propylparaben |
| 01/13/2009 | CA2605226C Nucleotide analog composition and synthesis method |
| 01/13/2009 | CA2470466C Combinations of viscoelastics for use during surgery |
| 01/13/2009 | CA2459175C An improved process for the synthesis of (±)2-amino-n-(2,(2,5-dimethoxyphenyl)-2-hydroxyethyl) acetamide monohydrochloride |
| 01/13/2009 | CA2445132C Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
| 01/13/2009 | CA2440186C Medicinal composition containing 1,3-thiazine derivative |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2400312C Nutritional intervention composition for enhancing and extending satiety |
| 01/13/2009 | CA2395333C Hydrogel-driven drug dosage form |
| 01/13/2009 | CA2392902C Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2386772C Pentacyclic taxane compound |
| 01/13/2009 | CA2385402C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 01/13/2009 | CA2382654C Novel a-500359 derivatives |
| 01/13/2009 | CA2369626C Use of cell membrane penetrating indigoid bisindole derivatives |
| 01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 01/13/2009 | CA2340118C Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| 01/13/2009 | CA2337397C 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/13/2009 | CA2315975C Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/13/2009 | CA2310659C Method for accelerating protein digestion rate |
| 01/13/2009 | CA2304704C Formulations and methods for reducing toxicity of antineoplastic agents |